Remove 2016 Remove Networking Remove Patients Remove Pharmaceutical research
article thumbnail

The Traditional Pharma Model Isn’t Working – It’s Time to Evolve!

PharmaKinnex

The pharmaceutical industry of 2022 is very different from the space that we all knew in 2012, 2016, or even 2020. – Increased Caution From Patients & Prescribers. As the pandemic ramped up, patients and prescribers ditched their traditional methods of interacting within the office and telemedicine became the new norm.

Pharma 52
article thumbnail

Paving the way for anti-Abeta active immunotherapy

European Pharmaceutical Review

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

article thumbnail

Shining a light on Raman for microbiological analysis

European Pharmaceutical Review

An example of such an application is for identifying biofilm-forming bacterial strains within a medical setting, which is of relevance for patient infection since many organisms associated with biofilms have strong resistance against antibiotics. Sci Rep, 2016; 6:34359 Shakeel M. Adv Appl Microbiol 2010; 70:153–186 Teng L, et al.